Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

NCT00296387 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1160

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Rosuvastatin
DRUG: Atorvastatin

Sponsor

AstraZeneca